Vaping: necessary clinic and functional indicators to assess tobacco harm reduction and related benefits

Tobacco harm reduction theories and their fundamental principles are questioned worldwide. New indicators specifically designed to establish the harm reduction potential of low risk tobacco products are examined by CoEHAR, with promising results

Continue ReadingVaping: necessary clinic and functional indicators to assess tobacco harm reduction and related benefits

Replica Project: a new study sets quality standards for the storage conditions of nicotine samples

The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products

Continue ReadingReplica Project: a new study sets quality standards for the storage conditions of nicotine samples

Latest study by CoEHAR aims to systematically review all the studies on health effects of e-cigarette substitution

The main goal of the protocol, the research project plan, is to examine the scientific evidence on the effects of e-cigarettes on smokers from the available studies. The project includes writing a paper for doctors and health care providers, a fact sheet for people who use e-cigarettes, and a policy brief for legislators on health committees

Continue ReadingLatest study by CoEHAR aims to systematically review all the studies on health effects of e-cigarette substitution

Gtfn 2020: Sustainability and Innovation are crucially for the future of Tobacco Harm Reduction

What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on

Continue ReadingGtfn 2020: Sustainability and Innovation are crucially for the future of Tobacco Harm Reduction

Tobacco Transformation Index finds most of the 15 Largest Tobacco Companies are failing to advance Harm Reduction

The first Tobacco Transformation Index, released today and made possible with funding from the Foundation for a Smoke-Free World, finds that most of the 15 largest tobacco companies are not making substantive progress in phasing out cigarettes and other high-risk tobacco products and transitioning smokers to reduced-risk alternatives

Continue ReadingTobacco Transformation Index finds most of the 15 Largest Tobacco Companies are failing to advance Harm Reduction